Prochilo T - Search Results

1

Secondary acute lymphoblastic leukaemia following oxaliplatin for adjuvant chemotherapy in colon cancer.

Merlin F, Prochilo T, Kildani B, Tucci A, Ferrari S, Rossi G, D'Adda P, Beretta GD. Merlin F, et al. Among authors: prochilo t. Acta Oncol. 2008;47(3):464-6. doi: 10.1080/02841860701558864. Epub 2007 Sep 12. Acta Oncol. 2008. PMID: 17851873 Review. No abstract available.

2

Colon cancer.

Labianca R, Beretta GD, Kildani B, Milesi L, Merlin F, Mosconi S, Pessi MA, Prochilo T, Quadri A, Gatta G, de Braud F, Wils J. Labianca R, et al. Among authors: prochilo t. Crit Rev Oncol Hematol. 2010 May;74(2):106-33. doi: 10.1016/j.critrevonc.2010.01.010. Crit Rev Oncol Hematol. 2010. PMID: 20138539 Review.

3

Colorectal cancer treatment in elderly patients: an update on recent clinical studies.

Merlin F, Prochilo T, Tondulli L, Kildani B, Beretta GD. Merlin F, et al. Among authors: prochilo t. Clin Colorectal Cancer. 2008 Nov;7(6):357-63. doi: 10.3816/CCC.2008.n.047. Clin Colorectal Cancer. 2008. PMID: 19036687

4

Chemotherapy rechallenge after regorafenib treatment in metastatic colorectal cancer: still hope after the last hope?

Bertocchi P, Aroldi F, Prochilo T, Meriggi F, Beretta GD, Zaniboni A. Bertocchi P, et al. Among authors: prochilo t. J Chemother. 2017 Apr;29(2):102-105. doi: 10.1080/1120009X.2016.1247205. Epub 2016 Dec 29. J Chemother. 2017. PMID: 28032528

5

Discoid lupus erythematosus (DLE)-like lesions induced by capecitabine.

Merlin F, Prochilo T, Kildani B, Lombardi C, Pasolini G, Bonetti F, Beretta GD. Merlin F, et al. Among authors: prochilo t. Int J Colorectal Dis. 2008 Jul;23(7):715-6. doi: 10.1007/s00384-008-0462-8. Epub 2008 Mar 11. Int J Colorectal Dis. 2008. PMID: 18330579 No abstract available.

6

Significance of neutrophil-to-lymphocyte ratio in Western advanced EGFR-mutated non-small cell lung cancer receiving a targeted therapy.

Meriggi F, Codignola C, Beretta GD, Ceresoli GL, Caprioli A, Scartozzi M, Fraccon AP, Prochilo T, Ogliosi C, Zaniboni A. Meriggi F, et al. Among authors: prochilo t. Tumori. 2017 Sep 18;103(5):443-448. doi: 10.5301/tj.5000632. Epub 2017 Jul 14. Tumori. 2017. PMID: 28731495

7

[The optimal duration of adjuvant therapy in breast cancer: what kind of evidence? Chemotherapy: what kind of evidence?].

Baldini E, Prochilo T. Baldini E, et al. Among authors: prochilo t. Suppl Tumori. 2004 Jul-Aug;3(4):S79-80. Suppl Tumori. 2004. PMID: 15206221 Review. Italian. No abstract available.

8

Blind Snipers: Relevant Off Target Effects of Non-chemotherapeutic Agents in Oncology: Review of the Literature.

Prochilo T, Di Biasi B, Aroldi F, Bertocchi P, Sabatini T, Meriggi F, Zaniboni A. Prochilo T, et al. Rev Recent Clin Trials. 2014;9(2):102-14. doi: 10.2174/1574887109666140522120931. Rev Recent Clin Trials. 2014. PMID: 24854040 Review.

9

Assessing cancer caregivers' needs for an early targeted psychosocial support project: The experience of the oncology department of the Poliambulanza Foundation.

Meriggi F, Andreis F, Premi V, Liborio N, Codignola C, Mazzocchi M, Rizzi A, Prochilo T, Rota L, Di Biasi B, Bertocchi P, Abeni C, Ogliosi C, Aroldi F, Zaniboni A. Meriggi F, et al. Among authors: prochilo t. Palliat Support Care. 2015 Aug;13(4):865-73. doi: 10.1017/S1478951514000753. Epub 2014 Jun 26. Palliat Support Care. 2015. PMID: 24968214

10

Oxaliplatin-induced hypersensitivity reaction: underlying mechanisms and management.

Aroldi F, Prochilo T, Bertocchi P, Zaniboni A. Aroldi F, et al. Among authors: prochilo t. J Chemother. 2015 Feb;27(2):63-6. doi: 10.1179/1973947814Y.0000000204. Epub 2014 Aug 6. J Chemother. 2015. PMID: 25096819 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

35 results

Search Page

Filters